We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

4 hedge funds and large institutions have $4.15M invested in Intra-Cellular Therapies Inc. in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 389 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 395 → 4 (-391)

100% less capital invested

Capital invested by funds: $13.6B → $4.15M (-$13.6B)

100% less funds holding in top 10

Funds holding in top 10: 52 → 0 (-52)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 389

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-391
Holders Change %
-98.99%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-52
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
389
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.26B
2
BlackRock
BlackRock
New York
-$1.15B
3
PCM
Pentwater Capital Management
Florida
-$685M
4
HI
HBK Investments
Texas
-$578M
5
Norges Bank
Norges Bank
Norway
-$472M
Name Holding Trade Value Shares
Change 		Change in
Stake
HFS
376
Hantz Financial Services
Michigan
– -$2K -14 Closed
WCM
377
Winthrop Capital Management
Indiana
– -$2K -13 Closed
PWAM
378
Private Wealth Asset Management
Iowa
– -$1.58K -12 Closed
CA
379
Clearstead Advisors
Ohio
– -$1.45K -11 Closed
BF
380
BOK Financial
Oklahoma
– -$1.32K -10 Closed
CT
381
Clearstead Trust
Maine
– -$1.19K -9 Closed
SC
382
SouthState Corp
Florida
– -$1.06K -8 Closed
NEWAS
383
N.E.W. Advisory Services
Wisconsin
– -$923 -7 Closed
CH
384
Cromwell Holdings
Wyoming
– -$792 -6 Closed
BWL
385
Bogart Wealth LLC
Virginia
– -$528 -4 Closed
CFO
386
CVA Family Office
Colorado
– -$528 -4 Closed
AF
387
Advisornet Financial
Minnesota
– -$264 -2 Closed
HWP
388
Highline Wealth Partners
California
– -$264 -2 Closed
MCM
389
MV Capital Management
Maryland
– -$264 -2 Closed
ACA
390
American Capital Advisory
Idaho
– -$132 -1 Closed
PFBT
391
Parkside Financial Bank & Trust
Missouri
– -$132 -1 Closed
TFM
392
TFC Financial Management
Massachusetts
– -$132 -1 Closed
WCM
393
WealthTrak Capital Management
Virginia
– -$132 -1 Closed
12 13 14 15
16

ITCI Hedge Fund Activity: Q2 2025 in Review

4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2025, worth a combined $4.15M — down 100% from $13.6B a quarter earlier.

Sellers outnumbered buyers: 389 funds closed out of ITCI and 0 opened new positions — a net loss of 389 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $1.26B sold.

  • 4 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2025, down from 395 in Q1 2025.
  • Funds reported $4.15M of Intra-Cellular Therapies Inc. stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2025 and 389 closed out, a net change of -389 holders.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2025 was Vanguard Group, an estimated $1.26B sold.

Based on aggregated 13F filings for Q2 2025.